Reuters -- Japan’s Dainippon Sumitomo Pharma Co Ltd said its experimental schizophrenia drug, lurasidone, was significantly better than placebo in a pivotal late-stage clinical trial, according to data released on Wednesday.
Reuters -- Japan’s Dainippon Sumitomo Pharma Co Ltd said its experimental schizophrenia drug, lurasidone, was significantly better than placebo in a pivotal late-stage clinical trial, according to data released on Wednesday.
